BetterLife Pharma Inc. (BETR.CN)
CAD 0.09
(0.0%)
CAD 0.09
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -2.47 Million | -1.5 Million | -11.2 Million | -7.16 Million | -7.88 Million | -4.97 Million |
| Net Income | -2.88 Million | -9.37 Million | -12.15 Million | -36.35 Million | -19.58 Million | -9.14 Million |
| Depreciation & Amortization | - | 18.43 Thousand | 18.43 Thousand | 342.81 Thousand | 1.4 Million | 900.65 Thousand |
| Deferred income taxes | - | 395.05 Thousand | 50.69 Thousand | 11.34 Million | 7.92 Million | 1.32 Million |
| Stock-based compensation | 500.26 Thousand | 951.06 Thousand | 1.23 Million | 826.63 Thousand | 1.59 Million | 31.56 Thousand |
| Change in working capital | 321.6 Thousand | 3.43 Million | -1.31 Million | -1.54 Million | 302.11 Thousand | 727.79 Thousand |
| Other non-cash items | 117.36 Thousand | 3.07 Million | 972.23 Thousand | 18.21 Million | 479.12 Thousand | 1.18 Million |
| Investing Cash Flow | - | 165.04 Thousand | -18.77 Thousand | -71.55 Thousand | -1.14 Million | -850.51 Thousand |
| Investments in PPE | - | - | - | -96.61 Thousand | -542.74 Thousand | -853.28 Thousand |
| Acquisitions | - | - | - | 25.06 Thousand | -432.92 Thousand | 2779.00 |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | -86.46 | -165.42 Thousand | -847.16 Thousand |
| Financing Cash Flow | 2.5 Million | 1.33 Million | 11.23 Million | 4.08 Million | 12.22 Million | 5.82 Million |
| Debt repayment | -300 Thousand | - | -250 Thousand | -499.92 Thousand | -3.83 Million | -770.52 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.2 Million | 833.31 Thousand | 11.44 Million | 1.28 Million | 16.31 Million | 1.53 Million |
| Other Financing Activities | 2.5 Million | 502.57 Thousand | 42.81 Thousand | 3.3 Million | -250 Thousand | 5.06 Million |
| Accounts receivables | -22.35 Thousand | 310.01 | 181.03 | -349.90 | -92.88 | -39.37 |
| Accounts payables | -701.56 Thousand | 2.21 Million | -1.15 Million | -993.93 Thousand | 1.05 Million | 470.78 Thousand |
| Inventory | - | 0.99 | - | - | -589.11 Thousand | 0.37 |
| Other working capital | 343.95 Thousand | 1.22 Million | -158.99 Thousand | -549.91 Thousand | -159 Thousand | 257.04 Thousand |
| Cash at beginning of period | 8307.00 | 173.51 Thousand | 154.72 Thousand | 3.28 Million | 74.8 Thousand | 79.3 Thousand |
| Cash at end of period | 37.38 Thousand | 8307.00 | 173.51 Thousand | 154.72 Thousand | 3.28 Million | 74.8 Thousand |
| Capital Expenditure | - | - | - | -96.61 Thousand | -542.74 Thousand | -853.28 Thousand |
| Effect of forex changes on cash | -56.00 | 2417.00 | -11.91 Thousand | 19.8 Thousand | 2218.00 | -3517.00 |
| Net cash flow / Change in cash | 29.07 Thousand | -165.2 Thousand | 18.79 Thousand | -3.12 Million | 3.2 Million | -4504.00 |
| Free Cash Flow | -2.47 Million | -1.5 Million | -11.2 Million | -7.26 Million | -8.42 Million | -5.83 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.44 Million | -1.94 Million | -1.3 Million | -2.88 Million | -213.73 Thousand | -1.02 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 24.53 Thousand | 1.62 Million | 61.46 Thousand | 500.26 Thousand | 112.32 Thousand | 232.2 Thousand |
| Change in working capital | 131.28 Thousand | -484.46 Thousand | 482.55 Thousand | 321.6 Thousand | 197.43 Thousand | 322.02 Thousand |
| Other non-cash items | 164.44 Thousand | 1.55 Million | 591.55 Thousand | 117.36 Thousand | -491.9 Thousand | 6925.00 |
| Investing Cash Flow | - | - | - | - | - | 186.29 Thousand |
| Investments in PPE | 1.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 705 Thousand | 1.24 Million | 200 Thousand | 2.5 Million | 427.4 Thousand | 280 Thousand |
| Debt repayment | - | -1.22 Million | -300 Thousand | -300 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -100 Thousand | - | - | - |
| Common Stock Issuance | 705 Thousand | 20.24 Thousand | 100 Thousand | 2.2 Million | 287.4 Thousand | 220 Thousand |
| Other Financing Activities | 20.24 Thousand | 20.24 Thousand | -200 Thousand | 2.5 Million | 140 Thousand | 60 Thousand |
| Accounts receivables | -2645.00 | 17.21 Thousand | -26.7 Thousand | -22.35 Thousand | -901.00 | 23.92 |
| Accounts payables | 125.5 Thousand | -422.85 Thousand | -82.8 Thousand | -701.56 Thousand | 63.35 Thousand | 62.74 Thousand |
| Inventory | - | - | - | - | 901.00 | 0.08 |
| Other working capital | 133.92 Thousand | -501.67 Thousand | 509.25 Thousand | 343.95 Thousand | 134.08 Thousand | 259.25 Thousand |
| Cash at beginning of period | 422.85 Thousand | 37.38 Thousand | 92.61 Thousand | 8307.00 | 60.99 Thousand | 247.47 Thousand |
| Cash at end of period | 126.3 Thousand | 422.85 Thousand | 37.38 Thousand | 37.38 Thousand | 92.61 Thousand | 60.99 Thousand |
| Capital Expenditure | 1.00 | - | - | - | - | - |
| Effect of forex changes on cash | 13.00 | 3.00 | -103.00 | -56.00 | 98.00 | -14.00 |
| Net cash flow / Change in cash | -296.54 Thousand | 385.46 Thousand | -55.23 Thousand | 29.07 Thousand | 31.62 Thousand | -186.48 Thousand |
| Free Cash Flow | -1 Million | -858.97 Thousand | -255.13 Thousand | -2.47 Million | -395.87 Thousand | -466.46 Thousand |
9594
WAY
ASTEC
SURAJEST
PLASTIBLEN
FIPP